Alector (ALEC) EV to CFO (2019 - 2026)
Alector's (ALEC) quarterly EV to CFO came in at 1.51 in Q2 2026, down 144.7% year-over-year from 3.38 in Q2 2025, and down 133.51% quarter-over-quarter from 0.65 in Q1 2026.
Analysis
Alector (ALEC) EV to CFO (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported EV to CFO for 8 consecutive years, with 1.51 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to CFO fell 144.7% year-over-year to 1.51 in Q2 2026; TTM through Jun 2026 was 0.33, a 142.49% decrease from a year earlier, with the FY2025 full-year figure at 0.46, down 53.67% from the prior year.
- EV to CFO was 1.51 for Q2 2026 at Alector, down from 0.65 in the prior quarter.
- Over five years, EV to CFO peaked at 4.11 in Q4 2024 and troughed at 2.79 in Q4 2023.
- A 5-year average of 0.87 and a median of 0.48 in 2023 frame the typical range for EV to CFO.
- The widest YoY moves for EV to CFO: up 1387.48% in 2025, down 5052.12% in 2025.
- Over 5 years, EV to CFO stood at 1.07 in 2022, then sank by 161.0% to 2.79 in 2023, then surged by 247.35% to 4.11 in 2024, then tumbled by 51.05% to 2.01 in 2025, then tumbled by 175.02% to 1.51 in 2026.
- The last three EV to CFO figures came in at 1.51 (Q2 2026), 0.65 (Q1 2026), and 2.01 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.51 |
| Mar 31, 2026 | -0.65 |
| Dec 31, 2025 | 2.01 |
| Sep 30, 2025 | -0.83 |
| Jun 30, 2025 | 3.38 |
| Mar 31, 2025 | 3.81 |
| Dec 31, 2024 | 4.11 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.98 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -2.79 |
| Sep 30, 2023 | 0.94 |
| Jun 30, 2023 | 2.94 |
| Mar 31, 2023 | 3.16 |
| Dec 31, 2022 | -1.07 |
| Sep 30, 2022 | -0.35 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | 2.22 |
| Dec 31, 2021 | -19.44 |
| Sep 30, 2021 | 2.32 |